Indications and uses
helps prevent sunburn if used as directed with other sun protection measure (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen
- Manufacturer
- Space Brands Limited
- Effective date
- 2014-03-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:38:46
Label at a glance#
ProductEve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen
Active ingredientTITANIUM DIOXIDE, OCTINOXATE
Label structure17 sections
Storage and handling
protect this product from excessive heat and direct sun
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
Active Ingredients Purpose
Octinoxate 3.9% Sunscreen
Titanium Dioxide 4% Sunscreen
Uses
- helps prevent sunburn
- if used as directed with other sun protection measure (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damages or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
- apply liberally 15 minutes before sun exposure
- children under 6 months of age: Ask a doctor
- reapply at least every 2 hours
- use a water-resistant sunscreen if swimming or sweating
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses
Inactive ingredients
ethylhexyl stearate, isononyl isononanoate, tribehenin, talc, caprylic/capric triglyceride, hydrogenated coco-glycerides, stearalkonium bentonite, hydrogenated polyisobutene, propylene carbonate, hydrogenated vegetable oil, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, nylon-12 fluorescent brightener 230 salt, hydrogenated styrene/isoprene copolymer, crithmum maritimum extract, polyvinylalcohol crosspolymer, BHT, rubus idaeus leaf cell culture.
May contain: titanium dioxide, iron oxides.
Other information
- protect this product from excessive heat and direct sun
PRINCIPAL DISPLAY PANEL - 2 g Container Carton - Alabaster
EVE LOM®
BRILLIANT COVER CONCEALER
BROAD SPECTRUM SPF 15
SUNSCREEN
ALABASTER 1
net wt 2g 0.07 OZ
PRINCIPAL DISPLAY PANEL - 2 g Container Carton - Ivory
EVE LOM®
BRILLIANT COVER CONCEALER
BROAD SPECTRUM SPF 15
SUNSCREEN
IVORY 2
net wt 2g 0.07 OZ
PRINCIPAL DISPLAY PANEL - 2 g Container Carton - Linen
EVE LOM®
BRILLIANT COVER CONCEALER
BROAD SPECTRUM SPF 15
SUNSCREEN
LINEN 4
net wt 2g 0.07 OZ
PRINCIPAL DISPLAY PANEL - 2 g Container Carton - Beige
EVE LOM®
BRILLIANT COVER CONCEALER
BROAD SPECTRUM SPF 15
SUNSCREEN
BEIGE 3
net wt 2g 0.07 OZ
PRINCIPAL DISPLAY PANEL - 2 g Container Carton - Wheat
EVE LOM®
BRILLIANT COVER CONCEALER
BROAD SPECTRUM SPF 15
SUNSCREEN
WHEAT 5
net wt 2g 0.07 OZ
PRINCIPAL DISPLAY PANEL - 2 g Container Carton - Glow
EVE LOM®
BRILLIANT COVER CONCEALER
BROAD SPECTRUM SPF 15
SUNSCREEN
GLOW 6
net wt 2g 0.07 OZ
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61601-1139-9 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3351-60a7-e053-dbdaa90a05bd | Eve Lom® Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen |
| 61601-1140-1 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3351-60a7-e053-dbdaa90a05bd | Eve Lom® Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen |
| 61601-1141-3 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3351-60a7-e053-dbdaa90a05bd | Eve Lom® Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen |
| 61601-1142-2 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3351-60a7-e053-dbdaa90a05bd | Eve Lom® Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen |
| 61601-1143-2 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3351-60a7-e053-dbdaa90a05bd | Eve Lom® Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen |
| 61601-1144-0 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3351-60a7-e053-dbdaa90a05bd | Eve Lom® Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61601-1139-9 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 61601-1139-9 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 2 g in 1 CONTAINER | CREAM | 2 | 1 | |
| 61601-1140-1 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 61601-1140-1 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 2 g in 1 CONTAINER | CREAM | 2 | 1 | |
| 61601-1141-3 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 61601-1141-3 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 2 g in 1 CONTAINER | CREAM | 2 | 1 | |
| 61601-1142-2 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 61601-1142-2 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 2 g in 1 CONTAINER | CREAM | 2 | 1 | |
| 61601-1143-2 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 61601-1143-2 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 2 g in 1 CONTAINER | CREAM | 2 | 1 | |
| 61601-1144-0 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 2 g in 1 CONTAINER | CREAM | 2 | 1 | |
| 61601-1144-0 | Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen | 1 in 1 CARTON | CREAM | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61601-1139 | EVE LOM BRILLIANT COVER CONCEALER BROAD SPECTRUM SPF 15 SUNSCREEN (TITANIUM DIOXIDE AND OCTINOXATE) CREAM [SPACE BRANDS LIMITED] | 1 | Legacy NDC, 2 package rows | 20140320_2e3dbc7d-d7e1-4808-ae49-8a63362af241.zip |
| 61601-1140 | EVE LOM BRILLIANT COVER CONCEALER BROAD SPECTRUM SPF 15 SUNSCREEN (TITANIUM DIOXIDE AND OCTINOXATE) CREAM [SPACE BRANDS LIMITED] | 1 | Legacy NDC, 2 package rows | 20140320_2e3dbc7d-d7e1-4808-ae49-8a63362af241.zip |
| 61601-1141 | EVE LOM BRILLIANT COVER CONCEALER BROAD SPECTRUM SPF 15 SUNSCREEN (TITANIUM DIOXIDE AND OCTINOXATE) CREAM [SPACE BRANDS LIMITED] | 1 | Legacy NDC, 2 package rows | 20140320_2e3dbc7d-d7e1-4808-ae49-8a63362af241.zip |
| 61601-1142 | EVE LOM BRILLIANT COVER CONCEALER BROAD SPECTRUM SPF 15 SUNSCREEN (TITANIUM DIOXIDE AND OCTINOXATE) CREAM [SPACE BRANDS LIMITED] | 1 | Legacy NDC, 2 package rows | 20140320_2e3dbc7d-d7e1-4808-ae49-8a63362af241.zip |
| 61601-1143 | EVE LOM BRILLIANT COVER CONCEALER BROAD SPECTRUM SPF 15 SUNSCREEN (TITANIUM DIOXIDE AND OCTINOXATE) CREAM [SPACE BRANDS LIMITED] | 1 | Legacy NDC, 2 package rows | 20140320_2e3dbc7d-d7e1-4808-ae49-8a63362af241.zip |
| 61601-1144 | EVE LOM BRILLIANT COVER CONCEALER BROAD SPECTRUM SPF 15 SUNSCREEN (TITANIUM DIOXIDE AND OCTINOXATE) CREAM [SPACE BRANDS LIMITED] | 1 | Legacy NDC, 2 package rows | 20140320_2e3dbc7d-d7e1-4808-ae49-8a63362af241.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| CRITHMUM MARITIMUM | INACTIVE INGREDIENT | J7IHY79BKY | 1 | |
| ETHYLHEXYL STEARATE | INACTIVE INGREDIENT | EG3PA2K3K5 | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| HYDROGENATED COCO-GLYCERIDES | INACTIVE INGREDIENT | XDD37N2GPR | 1 | |
| HYDROGENATED POLYBUTENE (1300 MW) | INACTIVE INGREDIENT | 7D1YQ9Y5EZ | 1 | |
| ISONONYL ISONONANOATE | INACTIVE INGREDIENT | S4V5BS6GCX | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) | INACTIVE INGREDIENT | 255PIF62MS | 1 | |
| PROPYLENE CARBONATE | INACTIVE INGREDIENT | 8D08K3S51E | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| TRIBEHENIN | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 |
Products#
Every source-derived product name is available through these pages.
- Eve Lom Brilliant Cover Concealer Broad Spectrum SPF 15 Sunscreen
- Titanium Dioxide and Octinoxate
- TITANIUM DIOXIDE
- OCTINOXATE
- ETHYLHEXYL STEARATE
- ISONONYL ISONONANOATE
- TRIBEHENIN
- TALC
- MEDIUM-CHAIN TRIGLYCERIDES
- HYDROGENATED COCO-GLYCERIDES
- FERRIC OXIDE YELLOW
- HYDROGENATED POLYBUTENE (1300 MW)
- FERRIC OXIDE RED
- PROPYLENE CARBONATE
- FERROSOFERRIC OXIDE
- PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE)
- CRITHMUM MARITIMUM
- BUTYLATED HYDROXYTOLUENE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 61601-1139 | 61601-1139-9 |
| 61601-1140 | 61601-1140-1 |
| 61601-1141 | 61601-1141-3 |
| 61601-1142 | 61601-1142-2 |
| 61601-1143 | 61601-1143-2 |
| 61601-1144 | 61601-1144-0 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE, LIQUID FILLED / ORAL | 0.1 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET / ORAL | 2 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE / ORAL | 5 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / ORAL | 24 mg | ||
| TALC | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | TABLET, FILM COATED / ORAL | 0.2 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM, AUGMENTED / TOPICAL | 0.2 %w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SOLUTION / ORAL | 5566 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | OINTMENT / TOPICAL | 57 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | FILM, SOLUBLE / ORAL | 0.06 mg | ||
| TALC | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 3.6 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | CAPSULE, COATED / ORAL | 0.01 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, DELAYED RELEASE / ORAL | 7 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 0.02 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | SUSPENSION, EXTENDED RELEASE / ORAL | 2.7 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE, EXTENDED RELEASE / ORAL | 0.03 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET, EXTENDED RELEASE / ORAL | 0.37 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | SUSPENSION / ORAL | 6 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, FILM COATED / ORAL | 3 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | POWDER, FOR SUSPENSION / ORAL | 1 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / RECTAL | 32.4 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, FOR SUSPENSION / ORAL | 0.1 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION / INTRAVENOUS | NA | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | AEROSOL, FOAM / TOPICAL | 4 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, EMULSION / INTRAVENOUS | 1.1 %w/v | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | POWDER / RESPIRATORY (INHALATION) | 0.04 mg | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE, COATED / ORAL | 0.11 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | 46 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | OINTMENT / TOPICAL | 20 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, EXTENDED RELEASE / ORAL | 1 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, CHEWABLE / ORAL | 14 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE / ORAL | 3 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / SUBLINGUAL | 1 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SWAB / TOPICAL | 0.5 %w/w | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / BUCCAL | 1 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GEL / TOPICAL | 8 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SHAMPOO / TOPICAL | 0.1 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0799bfca-4ae5-4bc5-a12c-da0d392c25bf | 2e3dbc7d-d7e1-4808-ae49-8a63362af241 | 2014-03-20 | Warnings | 0799bfca-4ae5-4bc5-a12c-da0d392c25bf 2e3dbc7d-d7e1-4808-ae49-8a63362af241 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.